1. Home
  2. FINS vs SPRC Comparison

FINS vs SPRC Comparison

Compare FINS & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FINS
  • SPRC
  • Stock Information
  • Founded
  • FINS 2019
  • SPRC 2004
  • Country
  • FINS United States
  • SPRC Israel
  • Employees
  • FINS N/A
  • SPRC N/A
  • Industry
  • FINS Finance/Investors Services
  • SPRC Biotechnology: Pharmaceutical Preparations
  • Sector
  • FINS Finance
  • SPRC Health Care
  • Exchange
  • FINS Nasdaq
  • SPRC Nasdaq
  • Market Cap
  • FINS 323.3M
  • SPRC 2.5M
  • IPO Year
  • FINS N/A
  • SPRC N/A
  • Fundamental
  • Price
  • FINS $12.78
  • SPRC $0.21
  • Analyst Decision
  • FINS
  • SPRC
  • Analyst Count
  • FINS 0
  • SPRC 0
  • Target Price
  • FINS N/A
  • SPRC N/A
  • AVG Volume (30 Days)
  • FINS 78.0K
  • SPRC 600.1K
  • Earning Date
  • FINS 01-01-0001
  • SPRC 02-15-2025
  • Dividend Yield
  • FINS 9.97%
  • SPRC N/A
  • EPS Growth
  • FINS N/A
  • SPRC N/A
  • EPS
  • FINS N/A
  • SPRC N/A
  • Revenue
  • FINS N/A
  • SPRC $1,747,000.00
  • Revenue This Year
  • FINS N/A
  • SPRC N/A
  • Revenue Next Year
  • FINS N/A
  • SPRC N/A
  • P/E Ratio
  • FINS N/A
  • SPRC N/A
  • Revenue Growth
  • FINS N/A
  • SPRC N/A
  • 52 Week Low
  • FINS $11.61
  • SPRC $0.20
  • 52 Week High
  • FINS $12.57
  • SPRC $6.78
  • Technical
  • Relative Strength Index (RSI)
  • FINS 45.94
  • SPRC 43.06
  • Support Level
  • FINS $12.82
  • SPRC $0.20
  • Resistance Level
  • FINS $13.11
  • SPRC $0.24
  • Average True Range (ATR)
  • FINS 0.11
  • SPRC 0.02
  • MACD
  • FINS -0.01
  • SPRC -0.00
  • Stochastic Oscillator
  • FINS 31.63
  • SPRC 14.64

About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest

Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: